Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
Recently the general medical literature has become aware that the use of certain long-acting
 insulin analogues could potentially increase cancer risk.During the last few years the
 investigators group generated information of both scientific and clinical relevance on the
 proliferative and anti-apoptotic actions of insulin analogues. The goal of this project is to
 evaluate the hypothesis that the proliferative and signalling activities elicited by insulin
 analogues may have a impact on tumor behavior. In this study the investigators will asses the
 biological actions of insulin analogs in primary tumor cells of endometrial and colon cancer.
Inclusion Criteria:

 -  Patients with Endometrial and Colon Cancer

 Exclusion Criteria:

 -  None